RxSight, Inc.
RxSight makes the Light Adjustable Lens™ (LAL®)—the only FDA-approved lens you can adjust after cataract surgery.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at RxSight, Inc.. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Medical Equipment Manufacturing
- Company size
- 410 people
- Headquarters
- Aliso Viejo, CA
- Founded
- 1997
- Type
- Public Company
- Total funding
- $351.0M
RxSight is a medical device company dedicated to transforming cataract surgery outcomes through the power of adjustability. The company makes the Light Adjustable Lens™ (LAL®), the only FDA-approved intraocular lens (IOL) that can be customized after cataract surgery using ultraviolet (UV) light treatments. Unlike traditional IOLs—which are fixed at the time of implantation—the LAL allows the treating physician to fine-tune the lens prescription after the eye has fully healed. This means patients receive a vision outcome tailored to their actual, post-surgical visual needs rather than a pre-surgical estimate. RxSight (Nasdaq: RXST) works with cataract surgeons and ophthalmologists to bring this personalized approach to vision care. For physicians, the LAL platform provides a clinical differentiation that no other premium IOL can match.
